Int J Stomatol ›› 2019, Vol. 46 ›› Issue (6): 730-734.doi: 10.7518/gjkq.2019090

• Reviews • Previous Articles     Next Articles

Effects of systemic and local factors on microbial homeostasis around implants

Huang Xiaoyu,Li Mingyun,Zhou Xue- dong,Cheng Lei()   

  1. State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & Dept. of Operative Dentistry and Endodontics, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China
  • Received:2019-02-05 Revised:2019-06-20 Online:2019-11-01 Published:2019-11-14
  • Contact: Lei Cheng E-mail:chengleidentist@163.com
  • Supported by:
    This study was supported by the 13th Five-year Plan of National Key Research and Development Program of China(2016YFC1102700)

Abstract:

Dental implantation is a routine treatment for tooth loss. With the increasing number of cases of planting failure, the main factor, peri-implantitis, has become the focus of experts and scholars. We recently found that certain systemic and local factors, such as smoking, drinking, diabetes, periodontitis, estrogen deficiency, oral hygiene, and cemented prostheses, may be involved in the occurrence, development, and prognosis of this disease. The Human Microbiome Project and other metagenomic projects worldwide have advanced our knowledge of the human oral microbiota, and the focus on the microbiology change of implants has gradually increased. We aimed to determine the influence of oral microbiota on the occurrence, development, and prognosis of peri-implant diseases by reviewing the recent research progress on peri-implant disease-related oral and systemic diseases.

Key words: peri-implant disease, oral microbiota, microbiological mechanism, systemic and local factor

CLC Number: 

  • R783.4

TrendMD: 
[1] Klinge B, Meyle J, Working Group 2. Peri-implant tissue destruction. The third EAO consensus confe-rence 2012[J]. Clin Oral Implants Res, 2012,23(Suppl 6):108-110.
[2] Srinivasan M, Vazquez L, Rieder P , et al. Survival rates of short (6 mm) micro-rough surface implants: a review of literature and meta-analysis[J]. Clin Oral Implants Res, 2014,25(5):539-545.
[3] Ogurtsova K, da Rocha Fernandes JD, Huang Y , et al. IDF Diabetes Atlas: global estimates for the preva-lence of diabetes for 2015 and 2040[J]. Diabetes Res Clin Pract, 2017,128:40-50.
[4] Al-Sowygh ZH, Ghani SMA, Sergis K , et al. Peri-implant conditions and levels of advanced glycation end products among patients with different glycemic control[J]. Clin Implant Dent Relat Res, 2018,20(3):345-351.
[5] Monje A, Catena A, Borgnakke WS . Association between diabetes mellitus/hyperglycaemia and peri-implant diseases: systematic review and meta-ana-lysis[J]. J Clin Periodontol, 2017,44(6):636-648.
[6] Al-Askar M, Ajlan S, Alomar N , et al. Clinical and radiographic peri-implant parameters and whole salivary interleukin-1β and interleukin-6 levels among type-2 diabetic and nondiabetic patients with and without peri-implantitis[J]. Med Princ Pract, 2018,27(2):133-138.
[7] Tatarakis N, Kinney JS, Inglehart M , et al. Clinical, microbiological, and salivary biomarker profiles of dental implant patients with type 2 diabetes[J]. Clin Oral Implants Res, 2014,25(7):803-812.
[8] Graves D . Cytokines that promote periodontal tissue destruction[J]. J Periodontol, 2008,79(8 Suppl):1585-1591.
[9] Xiao E, Mattos M, Vieira GHA , et al. Diabetes en-hances IL-17 expression and alters the oral micro-biome to increase its pathogenicity[J]. Cell Host Microbe, 2017,22(1): 120-128.e4.
[10] de Araújo Nobre M, Maló P . Prevalence of perio-dontitis, dental caries, and peri-implant pathology and their relation with systemic status and smoking habits: results of an open-cohort study with 22 009 patients in a private rehabilitation center[J]. J Dent, 2017,67:36-42.
[11] Saaby M, Karring E, Schou S , et al. Factors influen-cing severity of peri-implantitis[J]. Clin Oral Im-plants Res, 2016,27(1):7-12.
[12] Sgolastra F, Petrucci A, Severino M , et al. Smoking and the risk of peri-implantitis. A systematic review and meta-analysis[J]. Clin Oral Implants Res, 2015,26(4):e62-e67.
[13] Clementini M, Rossetti PH, Penarrocha D , et al. Sys-temic risk factors for peri-implant bone loss: a sys-tematic review and meta-analysis[J]. Int J Oral Ma-xillofac Surg, 2014,43(3):323-334.
[14] Joshi V, Matthews C, Aspiras M , et al. Smoking de-creases structural and functional resilience in the subgingival ecosystem[J]. J Clin Periodontol, 2014,41(11):1037-1047.
[15] Abduljabbar T, Akram Z, Vohra F , et al. Assessment of interleukin-1β, interleukin-6, and tumor necrosis factor-Α levels in the peri-implant sulcular fluid among waterpipe (narghile) smokers and never-smo-kers with peri-implantitis[J]. Clin Implant Dent Relat Res, 2018,20(2):144-150.
[16] Al-Sowygh ZH, Aldamkh MK, Binmahfooz AM , et al. Assessment of matrix metalloproteinase-8 and -9 levels in the peri-implant sulcular fluid among water-pipe (narghile) smokers and never-smokers with peri-implantitis[J]. Inhal Toxicol, 2018,30(2):72-77.
[17] Tsigarida AA, Dabdoub SM, Nagaraja HN , et al. The influence of smoking on the peri-implant microbiome[J]. J Dent Res, 2015,94(9):1202-1217.
[18] Duan XB, Wu TX, Xu X , et al. Smoking may lead to marginal bone loss around non-submerged implants during bone healing by altering salivary microbiome: a prospective study[J]. J Periodontol, 2017,88(12):1297-1308.
[19] Biswas SK, Mudi SR, Mollah FH , et al. Serum soluble receptor for advanced glycation end products (sRAGE) is independently associated with cigarette smoking in non-diabetic healthy subjects[J]. Diab Vasc Dis Res, 2013,10(4):380-382.
[20] Xu J, Xiong M, Huang B , et al. Advanced glycation end products upregulate the endoplasmic reticulum stress in human periodontal ligament cells[J]. J Perio-dontol, 2015,86(3):440-447.
[21] Petersen PE, Ogawa H . The global burden of perio-dontal disease: towards integration with chronic disease prevention and control[J]. Periodontol 2000, 2012,60(1):15-39.
[22] Altay MA, Tozoğlu S, Yıldırımyan N , et al. Is history of periodontitis a risk factor for peri-implant disease? A pilot study[J]. Int J Oral Maxillofac Implants, 2018,33(1):152-160.
[23] Renvert S, Quirynen M . Risk indicators for peri-implantitis. A narrative review[J]. Clin Oral Implants Res, 2015,26(Suppl 11):15-44.
[24] Greenwell H, Wang HL, Kornman KS , et al. Biolo-gically guided implant therapy: a diagnostic and therapeutic strategy of conservation and preservation based on periodontal staging and grading[J]. J Perio-dontol, 2019,90(5):441-444.
[25] Ferreira SD, Martins CC, Amaral SA , et al. Perio-dontitis as a risk factor for peri-implantitis: syste-matic review and meta-analysis of observational studies[J]. J Dent, 2018,79:1-10.
[26] Belibasakis GN . Microbiological and immuno-pa-thological aspects of peri-implant diseases[J]. Arch Oral Biol, 2014,59(1):66-72.
[27] Mombelli A, Décaillet F . The characteristics of bio-films in peri-implant disease[J]. J Clin Periodontol, 2011,38(Suppl 11):203-213.
[28] Maruyama N, Maruyama F, Takeuchi Y , et al. In-traindividual variation in core microbiota in peri-implantitis and periodontitis[J]. Sci Rep, 2015,4:6602.
[29] Persson GR, Renvert S . Cluster of bacteria associated with peri-implantitis[J]. Clin Implant Dent Relat Res, 2014,16(6):783-793.
[30] Li Y, Messina C, Bendaoud M , et al. Adaptive im-mune response in osteoclastic bone resorption in-duced by orally administered Aggregatibacter actin-omycetemcomitans in a rat model of periodontal disease[J]. Mol Oral Microbiol, 2010,25(4):275-292.
[31] Brasil SC, Santos RM, Fernandes A , et al. Influence of oestrogen deficiency on the development of apical periodontitis[J]. Int Endod J, 2017,50(2):161-166.
[32] de Medeiros FCFL, Kudo GAH, Leme BG , et al. Dental implants in patients with osteoporosis: a sys-tematic review with meta-analysis[J]. Int J Oral Maxillofac Surg, 2018,47(4):480-491.
[33] Vieira AT, Castelo PM, Ribeiro DA , et al. Influence of oral and gut microbiota in the health of menopausal women[J]. Front Microbiol, 2017,8:1884.
[34] Hernández-Vigueras S, Martínez-Garriga B, Sánchez MC , et al. Oral Microbiota, periodontal status, and osteoporosis in postmenopausal females[J]. J Perio-dontol, 2016,87(2):124-133.
[35] Renvert S, Polyzois I . Risk indicators for periim-plant mucositis: a systematic literature review[J]. J Clin Periodontol, 2015,42(Suppl 16):S172-S186.
[36] Serino G, Ström C . Peri-implantitis in partially eden-tulous patients: association with inadequate plaque control[J]. Clin Oral Implants Res, 2009,20(2):169-174.
[37] Korsch M, Walther W, Marten SM , et al. Microbial analysis of biofilms on cement surfaces: an investi-gation in cement-associated peri-implantitis[J]. J Appl Biomater Funct Mater, 2014,12(2):70-80.
[1] Zheng Guiting,Xu Yan,Wu Mingyue. Research progress and consensus of experts on the therapy of peri-implant diseases [J]. Int J Stomatol, 2020, 47(6): 725-731.
[2] Shujuan Guo, Qian Liu, Yi Ding. A brief introduction of the new classification scheme for periodontal and peri-implant diseases and conditions [J]. Int J Stomatol, 2019, 46(2): 125-134.
[3] Xia Ting, Shi Bin.. Research progress on the techniques to reduce excess cement around implant crowns [J]. Inter J Stomatol, 2017, 44(6): 721-725.
[4] Huang Hui, Zhang Qiong, Zou Jing. Research progress on oral microbiota of early childhood caries [J]. Inter J Stomatol, 2016, 43(3): 295-297.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[2] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[3] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[4] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[5] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[6] . [J]. Foreign Med Sci: Stomatol, 1999, 26(04): .
[7] . [J]. Foreign Med Sci: Stomatol, 2005, 32(06): 458 -460 .
[8] . [J]. Foreign Med Sci: Stomatol, 2005, 32(06): 452 -454 .
[9] . [J]. Inter J Stomatol, 2008, 35(S1): .
[10] . [J]. Inter J Stomatol, 2008, 35(S1): .